[ Price : $8.95]
FDA warns Lupin about CGMP violations and deviations at one of its units that are similar to those found in other Lupin facilities...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Lupin Limited, Shanghai Institute of Pharmaceutical Industry, Derma...[ Price : $8.95]
Heron Therapeutics resubmits an NDA for HTX-011, an investigational agent for managing postoperative pain.[ Price : $8.95]
Former FDA commissioner Robert Califf accepts a full-time role at Alphabet Company as the head of medical strategy and policy for ...[ Price : $8.95]
FDA clears a Luminex 510(k) for the Aries MRSA Assay, a real-time, polymerase chain reaction-based, in vitro diagnostic test for d...[ Price : $8.95]
FDA warns Chinas Shanghai Institute of Pharmaceutical Industry that the agency may withhold approval of ANDAs or supplements listi...[ Price : $8.95]
Four pharmaceutical stakeholders suggest edits to the FDA BEST glossary of biomarker, endpoints, and other tools.[ Price : $8.95]
AstraZeneca says it will work closely with FDA on next steps after receiving a complete response letter for its PT010 experimental...